← Back to Patent Explorer
US4299835A Expired / Lapsed US ⏱️ 0.0 years remaining

4-[(3-(4-Quinolyl)propyl])piperidines, their preparation and their use as medicines

Assignee: Pharmindustrie
•
Filing: 1980-11-24
•
Granted: 1981-11-10
•
Expires: 2000-11-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pharmaceutical preparations containing as active ingredient a compound having the formula: ##STR1## wherein R represents hydrogen, alkyl having 1 to 4 carbon atoms or alkenyl having 2 to 4 carbon atoms; and X represents hydrogen, alkyl, alkoxy or alkylthio, the alkyl groups of each containing 1 to 4 carbon atoms, halogen (chlorine, fluorine, bromine or iodine), trifluoromethyl, nitro, hydroxy, amino or amino substituted by one or two alkyl groups or by acyl or alkylsulphonyl, the alkyl groups of each containing 1 to 4 carbon atoms, which are particularly advantageous for the treatment of pathological states caused by a disturbance in the functioning of the serotoninergical systems in mammals. These preparations may also be used as anxiolytics.

Inventors

  • 👤 Alain A. Champseix
  • 👤 Claude G. A. Gueremy
  • 👤 Gerard R. Le Fur

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 23:54
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/06

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 113 words
A method of treating a mammal afflicted with an anxiety state comprising administering to said mammal a therapeutically effective amount of a composition comprising a compound of the formula: ##STR9## wherein R is hydrogen, alkyl having 1 to 4 carbon atoms or alkenyl having 2 to 4 carbon atoms; X is hydrogen or halogen, alkyl, alkoxy or alkylthio having 1 to 4 carbon atoms, trifluoromethyl, nitro, hydroxy, amino or amino substituted by one or two alkyl groups having 1 to 4 carbon atoms, by acyl having 1 to 4 carbon atoms or by alkylsulphonyl group having 1 to 4 carbon atoms, or a pharmaceutically acceptable salt thereof in a pharmaceutically acceptable carrier therefor.
Claim 2
Independent Claim 113 words
A method of treating a mammal afflicted with an anxiety state comprising administering to said mammal a therapeutically effective amount of a composition comprising a compound of the formula: ##STR9## wherein R is hydrogen, alkyl having 1 to 4 carbon atoms or alkenyl having 2 to 4 carbon atoms; X is hydrogen or halogen, alkyl, alkoxy or alkylthio having 1 to 4 carbon atoms, trifluoromethyl, nitro, hydroxy, amino or amino substituted by one or two alkyl groups having 1 to 4 carbon atoms, by acyl having 1 to 4 carbon atoms or by alkylsulphonyl group having 1 to 4 carbon atoms, or a pharmaceutically acceptable salt thereof in a pharmaceutically acceptable carrier therefor.
Claim 3
Dependent Claim 30 words
A method as defined in claim 1 wherein said compound corresponds to formula (I) wherein R is hydrogen, ethyl or vinyl and X is hydrogen or methoxy in position 6.
Claim 4
Dependent Claim 14 words
The method as defined in claim 1 wherein said compound is 4(R)-[3-(6-methoxy 4-quinolyl)propyl]3(R)-vinyl piperidine.
Claim 5
Dependent Claim 13 words
The method as defined in claim 1 wherein said compound is 4(R)-[3-(4-quinolyl)propyl]3(R)-vinyl piperidine.
Claim 6
Dependent Claim 13 words
The method as defined in claim 1 wherein said compound is 4(R)-[3-(6-methoxy-4-quinolyl)propyl]3(R)-ethyl piperidine.
Claim 7
Dependent Claim 12 words
The method as defined in claim 1 wherein said compound is 4-[3-(4-quinolyl)propyl]piperidine.
Claim 8
Dependent Claim 13 words
The method as defined in claim 1 wherein said compound is 4(R)-[3-(4-quinolyl)propyl]3(R)-ethyl piperidine.
Claim 9
Dependent Claim 12 words
The method of claim 1 wherein said compound is 4(R)-[3-(6-methoxy 4-quinolyl)propyl]3(S)-vinyl piperidine.
Claim 10
Dependent Claim 12 words
The method of claim 1 wherein said compound is 4(R)-[3-(6-methoxy 4-quinolyl)propyl]3(S)-ethyl piperidine.
Claim 11
Dependent Claim 12 words
The method of claim 1 wherein said compound is 4(R)-[3-(4-quinolyl)propyl]3(S) -vinyl piperidine.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-11-09 1985-05-11 1985-11-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-11-09 1989-05-11 1989-11-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-11-09 1993-05-11 1993-11-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag